Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Disease 3Prostatic Neoplasms 2Hereditary Cancer 2Colorectal Neoplasms 2Sarcoma, Kaposi 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain 1Neoplasms 1Lung Neoplasms 1Gynecologic Cancer 1Genetic Diseases, Inborn 1Development of the Virtual Biopsy 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colonic Neoplasms 1Chronic Pain 1Castleman Disease 1Cancer Pain 1COVID-19 1Breast Neoplasms 1Brain Neoplasms 1Anus Neoplasms 1Adenoma 1

Interventions

Temozolomide 163Radiosurgery 128Radiotherapy 106Bevacizumab 97Magnetic Resonance Spectroscopy 74Carboplatin 48Surgical Procedures, Operative 35Etoposide 34pembrolizumab 33Radiation 33Nivolumab 33Irinotecan 33Cyclophosphamide 33Erlotinib Hydrochloride 31Carmustine 28Trastuzumab 25Lomustine 25Cisplatin 25Ipilimumab 24Filgrastim 23Mental Status and Dementia Tests 21Magnetic Resonance Imaging 21Aminolevulinic Acid 21Vincristine 20Surveys and Questionnaires 19Capecitabine 19Topotecan 18Specimen Handling 18Pemetrexed 18Radiotherapy, Intensity-Modulated 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Diagnostic Tests, Routine × Clear all
NCT06501521 2025-07-18

Non-invasive Brain Tumor Molecular Diagnostics and Monitoring

The Institute of Molecular and Translational Medicine, Czech Republic

Recruiting
200 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡